Downregulation of Osteoblast Markers and Induction of the Glial Fibrillary Acidic Protein by Oncostatin M in Osteosarcoma Cells Require PKCδ and STAT3

The effects of OSM on proliferation and differentiation of osteosarcoma and nontransformed osteoblasts were analyzed. OSM downregulates osteoblast markers but induces the glial fibrillary acidic protein by the combined activation of PKCδ and STAT3, offering new lines of therapeutic investigations.

[1]  R. Baron,et al.  Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. , 2004, Endocrinology.

[2]  A. Miyajima,et al.  Essential Function of Oncostatin M in Nociceptive Neurons of Dorsal Root Ganglia , 2004, The Journal of Neuroscience.

[3]  T. Mcclanahan,et al.  WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 , 2004, The Journal of Immunology.

[4]  M. Katsuki,et al.  Targeted disruption of oncostatin M receptor results in altered hematopoiesis. , 2003, Blood.

[5]  S. Rose-John,et al.  Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130 , 2003, The Journal of Immunology.

[6]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[7]  E. Senba,et al.  Localization of oncostatin M receptor β in adult and developing CNS , 2003, Neuroscience.

[8]  A. Messing,et al.  GFAP: Functional implications gleaned from studies of genetically engineered mice , 2003, Glia.

[9]  A. Rowan,et al.  Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model. , 2003, The American journal of pathology.

[10]  H. Kamiya,et al.  Plasma levels of Th1 and Th2 cytokines in Ghanaian children with vaccine-modified measles. , 2003, European cytokine network.

[11]  B. Crain,et al.  Transplanted bone marrow generates new neurons in human brains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Ryoo,et al.  The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2* , 2003, The Journal of Biological Chemistry.

[13]  P. Conget,et al.  Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. , 2002, Experimental cell research.

[14]  G. Xiao,et al.  Fibroblast Growth Factor 2 Induction of the Osteocalcin Gene Requires MAPK Activity and Phosphorylation of the Osteoblast Transcription Factor, Cbfa1/Runx2* , 2002, The Journal of Biological Chemistry.

[15]  H. Baumann,et al.  FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins , 2002, Oncogene.

[16]  Anil K. Kamaraju,et al.  Pax3 Down-regulation and Shut-off of Melanogenesis in Melanoma B16/F10.9 by Interleukin-6 Receptor Signaling* , 2002, The Journal of Biological Chemistry.

[17]  B. Fuchs,et al.  Etiology of osteosarcoma. , 2002, Clinical orthopaedics and related research.

[18]  H. Baumann,et al.  Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms* , 2001, The Journal of Biological Chemistry.

[19]  J Kohyama,et al.  Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. , 2001, Differentiation; research in biological diversity.

[20]  M. Takagi,et al.  Differential Expression of Dentin Matrix Protein 1, Type I Collagen And Osteocalcin Genes in Rat Developing Mandibular Bone , 2001, The Histochemical Journal.

[21]  I. Fischer,et al.  In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. , 2001, Biochemical and biophysical research communications.

[22]  D. Heymann,et al.  gp130 Cytokine family and bone cells. , 2000, Cytokine.

[23]  T. Hara,et al.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. , 2000, The American journal of pathology.

[24]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[25]  H. Baumann,et al.  Oncostatin M and Interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells , 2000, Oncogene.

[26]  H. Baumann,et al.  Endotoxin-induced Renal Inflammatory Response , 2000, The Journal of Biological Chemistry.

[27]  S. Manolagas,et al.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.

[28]  C. Begley,et al.  The oncostatin M signalling pathway: reversing the neoplastic phenotype? , 1999, Molecular medicine today.

[29]  G. Stein,et al.  The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts. , 1999, Cancer research.

[30]  K. Nakashima,et al.  STAT3-mediated astrocyte differentiation from mouse fetal neuroepithelial cells by mouse oncostatin M , 1999, Neuroscience Letters.

[31]  U. Klingmüller,et al.  Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1 , 1999, Oncogene.

[32]  P. Patterson,et al.  Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury , 1999, Stem cells.

[33]  K. Miyazono,et al.  Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.

[34]  Yoshiaki Ito,et al.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer , 1999, The EMBO journal.

[35]  S. Bohic,et al.  Effects of leukemia inhibitory factor and oncostatin M on bone mineral formed in in vitro rat bone-marrow stromal cell culture: physicochemical aspects. , 1998, Biochemical and biophysical research communications.

[36]  G. Daculsi,et al.  Leukemia Inhibitory Factor and Oncostatin M Influence the Mineral Phases Formed in a Murine Heterotopic Calcification Model: A Fourier Transform‐Infrared Microspectroscopic Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  P. Roberson,et al.  Transcriptional Activation of the p21 WAF1,CIP1,SDI1 Gene by Interleukin-6 Type Cytokines , 1998, The Journal of Biological Chemistry.

[38]  A. Gupta,et al.  LIF, but Not IL‐6, Regulates Osteoprogenitor Differentiation in Rat Calvaria Cell Cultures: Modulation by Dexamethasone , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  V. Kasantikul,et al.  Positivity to glial fibrillary acidic protein in bone, cartilage, and chordoma , 1989, Journal of surgical oncology.

[40]  K. Unni,et al.  Osteosarcoma of bone and its important recognizable varieties , 1977, The American journal of surgical pathology.

[41]  A. Miyajima,et al.  Oncostatin M, a multifunctional cytokine. , 2003, Reviews of physiology, biochemistry and pharmacology.

[42]  E. Senba,et al.  Localization of oncostatin M receptor beta in adult and developing CNS. , 2003, Neuroscience.

[43]  U. Lerner,et al.  Calvariae B in Mouse κ and Receptor Activator of NFB Ligand , Osteoprotegerin , κ Activator of NF-Regulate the Expression of Receptor Oncostatin M Stimulate Bone Resorption and IL-6 , Leukemia Inhibitory Factor , and , 2002 .

[44]  H. Baumann,et al.  Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. , 2001, The Journal of biological chemistry.

[45]  中澤 英子.  Ultrastructural observations of astrocyte end-feet in the rat central nervous system , 1999 .

[46]  H. Halfter,et al.  Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM). , 1998, Growth factors.

[47]  P. Linsley,et al.  Regulation of cell growth by recombinant oncostatin M. , 1990, Growth factors.

[48]  E. Lubberts,et al.  Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. , 2002, The American journal of pathology.

[49]  P. Roberson,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Activation of the Janus Kinase/STAT (Signal Transducer and Activator of Transcription) Signal Transduction Pathway by Interleukin-6-Type Cytokines Promotes , 2022 .